EPIDITHIODIOXOPIPERAZIN-VERBINDUNG ODER DERIVAT DAVON ODER PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR PRÄVENTION ODER BEHANDLUNG VON PULMONALER HYPERTONIE MIT PHARMAZEUTISCH UNBEDENKLICHEN SALZEN DAVON

European patent · EP3650026 · In force

Register entry

Publication number
EP3650026
Application number
EP18828466
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 5, 2018
Published
May 13, 2020
Granted
Oct 1, 2025
Protection ends at the latest
Jul 4, 2038
Next annual fee due
Jul 31, 2026
IPC classes
A61K 31/549 (2006.01)
A61K 31/548 (2006.01)
A61P 9/12 (2006.01)
Priority
KR 20170085656 05.07.2017
KR 20180001889 05.01.2018
PCT application
PCT/KR2018/007649 05.07.2018
PCT publication
WO2019/009646 10.01.2019
Filing language
Korean
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 12, 2026

    Change

    Published in Swissreg on 12.08.2026

  2. Oct 1, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 01.10.2025

Parties

Holder

VASTHERA Co. Ltd.

504, Science building C, 52, Ewhayeodae-gil, Seodaemun-gu,, Seoul 03760, KR

Inventor

KANG, Sang Won

Seoul 06517, KR

KWON, Kihwan

Seoul 06009, KR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.